Avarieux
back to explore
Liquidia Corp logo

LQDA

Liquidia Corp
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2018-07-26
$69.68
+2.77 (+4.14%)
last quote
Want the full multi-source brief on LQDA?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$69.68
High
$70.09
Low
$66.73
Previous close
$66.91
Fundamentals
Market cap
$6.41B
P/E (TTM)
287.46x
P/S (TTM)
22.26x
P/B
12.93x
Gross margin
91.82%
Operating margin
15.81%
Net margin
7.74%
Rev growth (YoY)
1936.66%
EPS growth (YoY)
—
ROE
46.82%
52W high
$93.61
52W low
$21.15
Beta
0.41x
Industry peers
by market cap
CORT-2.60%AXSM+3.50%BLTE+2.53%AMRX+2.15%LGND+0.93%DFTX+1.04%EWTX-0.64%AMLX+2.01%
Upcoming earnings
next 30 days
2026-11-02in 59 daysbefore market
Q3 2026EPS est $0.86Rev est $200.5M
Recent SEC filings
CIK 1819576filing-language history →
42026-08-25reports 2026-08-21
22 KB
1442026-08-21
6 KB
42026-08-21reports 2026-08-19
22 KB
42026-08-19reports 2026-08-17
12 KB
1442026-08-19
5 KB
1442026-08-19
6 KB
Recent news
2026-08-27 → 2026-09-03
SeekingAlpha · 5d
Liquidia: A Linear Launch Priced For Exponential Growth
Liquidia Corporation is rated Sell as YUTREPIA growth is slowing, valuation tops $6B, and the TPIP threat looms. Click for this LQDA stock update.
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial